Page 14 - JSOM Summer 2025
P. 14

Lessons learned over the next several decades, including   (similar to ROLO), it also places emphasis on using existing
          through U.S. involvement in the Global War on Terror, demon-  DoD systems to support the drawing, testing, labeling, and
          strated a shift in focus back to blood products for resuscitation   storing of blood rather than relying solely on walking blood
                                                                  13
          of hemorrhagic shock, with WB emerging as the fluid of choice   banks.  The SOLO protocol recognizes that walking blood
                         4–7
          when it is available.  Typed and matched WB is primary in the   bank–procured  FWB  is not  an FDA-licensed  product and,
          non-emergent, hospital setting, though low-titer O type blood   therefore, should not be thought of as a primary method for
          is now recognized as the standard of care across the Advanced   meeting CONUS blood needs. It reiterates that walking blood
          Trauma Life Support (ATLS) and Joint Trauma System (JTS)   bank FWB has an increased risk to forces when compared to
          protocols for prehospital or emergency trauma care. Product   FDA-approved cold whole blood (CWB) due to the latter’s
          Component therapy at a 1:1:1:1 ratio (packed red blood cells   risk of transfusion-transmitted infections and increased risk of
          [pRBC], platelets, plasma, CRP) remains an acceptable option   clerical errors leading to transfusion mismatch. 14
                              8,9
          when WB is unavailable.  Intuitively, as the body loses WB,
          WB should replace it. This is borne out in current literature as   As medics and providers with significant SOF experience, 2/1
          well. However, there are many logistical challenges associated   SFG(A) Med recognizes that there is rarely a single solution
          with WB on the battlefield, given the need for either immediate   to a complex issue such as point of injury blood transfusion.
          use, or tightly temperature-controlled storage.    Unit structure, operational setting, and geographic location
                                                             will affect medical practice and Commanders’ responses to
          The Ranger O Low-Titer (ROLO) program, one well publi-  risk. Guidelines from CoTCCC, JTS, SOCOM, and other or-
          cized SOF-led initiative, sought to mitigate barriers to WB far   ganizations provide a litany of deployed protocols ranging
          forward on the battlefield. ROLO depends on drawing of units   from obtaining blood/blood products from the ASPB supply,
          of WB from Rangers who have been pre-screened as having   to pre-screened low-titer O type blood drawn as needed, to
          low-titer O type blood. For the purposes of this and other De-  the establishment of walking blood banks organic to the force.
          partment of Defense (DoD) programs, low titer is defined as   The same is not true for the CONUS environment. Despite
                                                         10
          blood group O, with IgM, anti-A, and anti-B titers <1:256.    current data suggesting that 32% of non-overseas deaths of
          Under a ROLO protocol, once a massive transfusion scenario   active-duty Servicemembers occurred due to accidents,  there
                                                                                                       15
          takes place, pre-identified Ranger donors serve as a walking   is currently no guidance on storage and transfusion of blood
          blood bank of fresh whole blood (FWB) for purpose of resusci-  products for SOF elements in the CONUS setting. As a result
          tating critically wounded unit members. This protocol has be-  of this paucity of guidance, very few SOF units routinely carry
          come highly praised and was recognized by the Army Materiel   blood or blood products on training missions within the U.S.,
          Command as the individual military winner of the annual Ar-  regardless of risk level or proximity to definitive care. It is our
          my’s Greatest Innovation Award in 2014. It has been effective   belief that this has led to training scares and violates the mili-
          in saving the lives of combat casualties in at least one docu-  tary mantra of “train as you fight.” FWB donated from emer-
          mented case, in Wardak Province in 2020.  Despite the over-  gency unit walking blood banks is part of training in Special
                                           11
          whelming success of the ROLO protocol, there are significant   Operations  Combat Medic  (SOCM)-producing  courses and
          barriers to its broad application to all units, even within SOF.  re-trained and assessed at the refresher and team level; autol-
                                                             ogous FWB transfusion for the purpose of training is com-
          While JTS clinical practice guidelines (CPGs) state that FWB   monplace throughout SOF and beyond. Conversely, proper
          donors have not shown significant decrements in military-   maintenance, transport, and transfusion of CWB is rarely dis-
                                              10
          relevant task performance following donation,  other studies   cussed and exercised, despite its improved safety profile and
          argue that although negative physiological effects on the in-  often improved practicality.
          dividual donor are minimal, they claim consensus on the fact
                                         12
          that performance is temporarily reduced.  In the heat of battle,   Study purpose
          it is instinctively unfavorable to return Servicemembers who   Understanding that walking blood bank procured FWB does
          have recently donated blood to a situation where they have a   not answer the organizational concerns of Special Forces ODA
          higher likelihood of becoming casualties themselves. If injured,   and USSOCOM guidance favoring prioritization of ASBP-sup-
          they would begin with the disadvantage of having less blood   plied, FDA-approved CWB. Also considering additional qual-
          volume than they would otherwise have had. Moreover, JTS   ity restraints when practicing in the U.S., the medical section
          CPGs suggest that, due to the potentially chaotic conditions in   at 2/1 SFG(A) developed a feasibility study to determine if the
          which FWB such as ROLO is used, there is an increased risk   organic capability existed to store and transport CWB to po-
          of transfusion-transmitted infections (e.g., HIV, hepatitis B or   tential points of injury within CONUS. While conducting typi-
          C, syphilis), and an increased risk of clerical errors leading to   cal unit training, SOF Operators brought CWB to the training
          major mismatches. For SOF units structured or immediately   sites where the medics tracked the product’s refrigerated lifes-
          supported by platoon or company-sized elements, these costs   pan. We  hypothesized  this  capability  would  be  feasible  and
          and considerations might be offset by the size of the available   that demonstrating success would lead to additional studies
          donor pool and accompanying manpower. Though some SOF   and  pilot  programs,  facilitate  novel  methods  of  blood  pro-
          units are routinely organized into elements of 4–12 Operators,   curement to mitigate training risk in the CONUS pre-hospital
          even temporarily removing a portion of the fighting force rep-  setting, and improve our medics’ competence in working with
          resents the potential for critical degradation in capability to   CWB in any setting.
          perform continuing operations.
                                                             Methods
          Special Operations Command (SOCOM) at large has estab-
          lished a Special Operations Low-Titer O Blood (SOLO) pro-  Three male volunteers aged 25–41 years were selected from
          gram.  While this protocol ultimately supports the use of a   2Bn 1SFG(A) Support Company. Their selection was based
          walking blood bank program with low-titer O whole blood   on gender, volunteerism, and the criteria that they had not

          12  |  JSOM   Volume 25, Edition 2 / Summer 2025
   9   10   11   12   13   14   15   16   17   18   19